Literature DB >> 10704333

Effective construction of DNA vaccines against variable influenza genes by homologous recombination.

K Ljungberg1, B Wahren, J Almqvist, J Hinkula, A Linde, G Winberg.   

Abstract

We demonstrate the potential of cloning by homologous recombination as a rapid method to construct DNA molecules encoding newly developing hemagglutinins (HA) of influenza A virus. The variable parts of the HA genes were cloned into a basic construct containing the HA gene from an H3N2 strain. The recombinant DNAs thus created encode different variable domains with neutralising epitopes from four recently circulating influenza A H3 strains. The technology allows rapid production of DNA constructs for vaccines that can induce antibody and, particularly, cellular immune responses. These new constructs were also capable of conferring protection to challenge in mice. The technology may hence be a valuable tool for rapid adaptation of influenza vaccines to changes in the circulating influenza strains. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704333     DOI: 10.1006/viro.2000.0199

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

Review 1.  Influenza vaccines: present and future.

Authors:  Peter Palese; Adolfo García-Sastre
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.

Authors:  Jehad Charo; Jan Alvar Lindencrona; Lena-Maria Carlson; Jorma Hinkula; Rolf Kiessling
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.

Authors:  Liyun Zheng; Fuyan Wang; Zhongdong Yang; Jianjun Chen; Haiyan Chang; Ze Chen
Journal:  BMC Infect Dis       Date:  2009-02-12       Impact factor: 3.090

4.  Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature.

Authors:  Ze Liu; Xingliang Geng; Zhaohai Cui; Weidong Li; Xia Ou; Guoyang Liao
Journal:  J Cell Mol Med       Date:  2020-09-09       Impact factor: 5.310

5.  HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Authors:  J Hinkula; S Petkov; K Ljungberg; D Hallengärd; A Bråve; M Isaguliants; T Falkeborn; S Sharma; V Liakina; M Robb; M Eller; B Moss; G Biberfeld; E Sandström; C Nilsson; K Markland; P Blomberg; B Wahren
Journal:  Heliyon       Date:  2017-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.